Categories: Budget

Pre-Budget Expectations by Ms. Pushpa Vijayaraghavan, Director – Healthcare & Lifesciences advisory, Sathguru Management Consultants

New Delhi, February 01, 2018: Two changes will be critical for the pharma and biotech segments – 

  1. Innovation incentives – Fiscal incentives promoting R&D have gone down with the last budget in India while they have been continuously strengthened in other countries. As an industry in transition from a pure paly generics stronghold to being more innovation led, it is critical that the Budget offers fiscal incentives for not only in-house R&D but also technology acquired from external sources, whether domestic or international.
  2. Import duty structure that considers need to reduce dependence on Chinese API and provide a level-playing field to domestic API manufacturers – we have a dire situation where the country has negligible level of domestic production in the case of critical antibiotic API and at the other end, several small to medium API companies face the risk of insolvency. There has been an unsustainable business environment in API with  unfair price manipulation by Chinese API companies.  To ensure access to API is not a threat as a country and Make-in-India is not an elusive dream for API, it is important that we respond with fiscal and trade regulation changes that protect domestic companies from such unfair trade practices.

 

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

7 hours ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

1 day ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

4 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

5 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

6 days ago